2-AG |
2-arachidonoylglycerol |
5-HT1A |
5-hydroxytryptamine receptor subtype 1A |
AD |
Alzheimer’s disease |
Ads |
Autoimmune diseases |
AEA |
N-arachidonoylethanolamide/anandamide |
BBB |
Blood brain barrier |
cAMP |
Cyclic adenosine monophosphate |
CAT |
Catalase |
CB1 |
Cannabinoid receptors 1 |
CB2 |
Cannabinoid receptors 2 |
CBD |
Cannabidiol |
CBG |
Cannabigerol |
CGD |
Chronic granulomatous diseases |
CNS |
Central nervous system |
COX |
Cyclooxygenase |
CRC |
Colorectal cancer |
DAGLα/β |
Diacylglycerol lipase-α and -β |
DAGs |
Diacylglycerols |
EAE |
Autoimmune encephalomyelitis |
ECs |
Endocannabinoids |
ECS |
Endocannabinoid system |
FAAH |
Fatty acid amide hydrolase |
GPCRs |
G-protein-coupled receptor |
GPR55 |
G-protein-coupled receptor 55 |
GPx |
Glutathione peroxidase |
GSH |
Glutathione |
H2O2 |
Hydrogen peroxide |
HD |
Huntington’s disease |
HO• |
Hydroxyl radical |
IB |
Inflammatory bowel disease |
iNOS |
Inducible nitric oxide synthase |
IS |
Immune system |
LDL |
Low-density lipoproteins |
LPS |
Lipopolysaccharide |
MAGL |
Monoacyl glycerol lipase |
MAPK |
Mitogen-activated protein kinase |
MS |
Multiple sclerosis |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
NAPE |
N-arachidonoyl phosphatidyl ethanolamine |
NMDAr |
N-methyl-D-aspartate receptor |
NOX1 |
NADPH oxidase 1 |
NOX2 |
NADPH oxidase 2 |
NOX4 |
NADPH oxidase 4 |
O2 •− |
Superoxide anion |
PD |
Parkinson’s disease |
PI3K |
Phosphoinositide 3-kinase |
PNS |
Peripheral nervous system |
PPARs |
Peroxisome proliferator-activated receptors |
RA |
Rheumatoid arthritis |
Redox |
Reduction-oxidation |
RNS |
Reactive nitrogen species |
ROS |
Reactive oxygen species |
SCBs |
Synthetic cannabinoids |
SOD |
Superoxide dismutase |
T1DM |
Type 1 diabetes mellitus |
THC |
Delta-9-tetrahydrocannabinol |
TLR4 |
Toll-like receptor 4 |
TRPV1 |
Transient receptor potential cation channel subfamily V member 1 |
VLDL |
Low density lipoprotein |
XO |
Xanthine oxidase |